Assessment of potential predictive value o f peripheral blood inflammatory indexes in 26 cases with soft tissue sarcoma treated by pazopanib: a retrospective study

MİRİLİ, CEM; Payday, Semra; GÜNEY, İSA; OĞUL, ALİ; GÖKÇAY, SERKAN; BÜYÜKŞİMŞEK, MAHMUT; YETİŞİR, ABDULLAH; Karaalioglu, Bilgin; TOHUMCUOĞLU, MERT; SEYDAOĞLU, GÜLŞAH

doi:10.2147/cmar.s191199

Assessment of potential predictive value o f peripheral blood inflammatory indexes in 26 cases with soft tissue sarcoma treated by pazopanib: a retrospective study

Copy For Citation

MİRİLİ C., Payday S., GÜNEY İ. B., OĞUL A., GÖKÇAY S., BÜYÜKŞİMŞEK M., ...More

CANCER MANAGEMENT AND RESEARCH, vol.11, pp.3445-3453, 2019 (SCI-Expanded)

Publication Type: Article / Article
Volume: 11
Publication Date: 2019
Doi Number: 10.2147/cmar.s191199
Journal Name: CANCER MANAGEMENT AND RESEARCH
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.3445-3453
Keywords: soft tissue sarcoma, STS, pazopanib, angiogenesis, inflammation, neutrophil-to-lymphocyte ratio, NLR, derived neutrophil-to-lymphocyte ratio, DNLR, PROGNOSTIC-FACTORS, LYMPHOCYTE RATIO, CANCER, ANGIOGENESIS, BIOMARKERS, NEUTROPHIL, SURVIVAL, MONOCYTE
Çukurova University Affiliated: Yes

Abstract

Purpose: The aim of this study was to evaluate the prognostic and predictive value o f neutrophilto-lymphocyte ratio (NLR), derived neutrophil-to-lymphocyte ratio (DNLR), lymphocyte-tomonocyte ratio (LMR), and platelet-to-lymphocyte ratio (PLR) in soft tissue sarcoma (STS) cases treated with pazopanib.